BIOGEN logo

Biogen Pharmachem Industries Ltd

BIOGEN·BSE·
0.27 -0.01 (-3.57%)
Market Cap29.49 Cr
PE Ratio
Volume30,04,786
Day High - Low0.28 - 0.27
52W High-Low0.84 - 0.26
DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
0.90%
Weak
P/E
Debt / Equity
0.00
Low
Industry
Financial Services
Other Financial Services
Overall View
Mixed

Price performance

Day0.27
0.28
52W0.26
0.84
DocStoX take

Supported by growth (9.0) and valuation (7.5), but held back by momentum (0.0). Growth looks strong at 9.0, but that is offset by momentum at 0.0 and quality at 1.3. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.5
/10
Weak
Quality
Weak
ROE 0.9%
Valuation
Cheap
P/B 0.3× vs 0.6× warranted by ROE
Growth
Strong
Profit +23.2% 3Y CAGR
Risk
Moderate
D/E 0.00 (lender)
Momentum
Weak
2% of 52-week range

At a glance

Market Cap
₹29 Cr
52W High / Low
₹1 / ₹0
Dividend Yield
0.00%
Promoter Holding
0.00%
EPS (TTM)
₹0.00
Book Value
₹0.94

Key highlights

  • Profit compounding 23% a year
  • Loss-making in some of the last 5 years
  • Quality is weak (1.3/10)
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Financial Services stocks · Other Financial Services

Biogen Pharmachem Industries Ltd peers in Financial Services

Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.